Monoclonal Antibody to Domain I of β2-glycoprotein I Prevents the Thrombotic Diathesis Associated With the Antiphospholipid Syndrome

被引：0
|
作者：
Lanier, Lane [1 ]
Ulrich, Victoria [1 ]
Tarango, Cristina [1 ]
Yuhanna, Ivan [1 ]
Morrell, Craig N. [2 ]
Shen, Yu-Min [1 ]
Shaul, Philip W. [1 ]
Mineo, Chieko [1 ]
机构：
[1] UT SW Med Ctr Dallas, Dallas, TX USA
[2] Univ Rochester, Aab Cardiovasc Rsch Inst, West Henrietta, NY USA
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Thrombosis; Endothelial function; Monoclonal antibodies; Immune system;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12956
引用
收藏
页数：1
相关论文
共 50 条
  • [1] β2-glycoprotein I, the playmaker of the antiphospholipid syndrome
    de Laat, HB
    Derksen, RHWM
    de Groot, PG
    CLINICAL IMMUNOLOGY, 2004, 112 (02) : 161 - 168
  • [2] Specificity of ELISA for antibody beta 2-glycoprotein I in patients with antiphospholipid syndrome
    Amengual, O
    Atsumi, T
    Khamashta, MA
    Koike, T
    Hughes, GRV
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (12): : 1239 - 1243
  • [3] Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome
    Mondejar, R.
    Gonzalez-Rodriguez, C.
    Toyos-Saenz de Miera, F. J.
    Melguizo-Madrid, E.
    Zohoury, N.
    Mahler, M.
    Romero Losquino, I.
    Fabiani, F.
    CLINICA CHIMICA ACTA, 2014, 431 : 174 - 178
  • [4] The clinical value of assays detecting antibodies against domain I of β2-glycoprotein I in the antiphospholipid syndrome
    Yin, Dongmei
    de Laat, Bas
    Devreese, Katrien M. J.
    Kelchtermans, Hilde
    AUTOIMMUNITY REVIEWS, 2018, 17 (12) : 1210 - 1218
  • [5] Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    T. M. Reshetnyak
    F. A. Cheldieva
    M. V. Cherkasova
    S. I. Glukhova
    A. M. Lila
    E. L. Nasonov
    Doklady Biochemistry and Biophysics, 2023, 511 : 219 - 226
  • [6] Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    Reshetnyak, T. M.
    Cheldieva, F. A.
    Cherkasova, M. V.
    Glukhova, S. I.
    Lila, A. M.
    Nasonov, E. L.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2023, 511 (01) : 219 - 226
  • [7] Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome
    Iwaniec, Teresa
    Kaczor, Marcin P.
    Celinska-Lowenhoff, Magdalena
    Polanski, Stanislaw
    Musial, Jacek
    THROMBOSIS RESEARCH, 2017, 153 : 90 - 94
  • [8] Domain I of β2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome
    Ioannou, Y.
    Rahman, A.
    LUPUS, 2010, 19 (04) : 400 - 405
  • [9] Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S.
    Kveder, T.
    Artenjak, A.
    Gallova, Z. Ulcova
    Swadzba, J.
    Musial, J.
    Iwaniec, T.
    Stojanovich, L.
    Alessandri, C.
    Valesini, G.
    Avcin, T.
    Tervaert, J. W. Cohen
    Rozman, B.
    Bozic, B.
    LUPUS, 2012, 21 (07) : 764 - 765
  • [10] Autoantibodies to β2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome:: Clinical correlations in comparison with other antiphospholipid antibody tests
    Day, HM
    Thiagarajan, P
    Ahn, C
    Reveille, JD
    Tinker, KF
    Arnett, FC
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (04) : 667 - 674
12345